New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|January 1, 2002
The American Journal of Managed Care
- January 2002
- Volume 8
- Issue 1
Postmenopausal Hormone Replacement Therapy and Major Clinical Outcomes: A Focus on Cardiovascular Disease, Osteoporosis, Dementia, and Breast and Endometrial Neoplasia
Advertisement
Articles in this issue
over 24 years ago
TennCare - Medicaid Managed Care in Tennessee in Jeopardyover 24 years ago
Effects of Restrictive Formularies in the Ambulatory Care Settingover 24 years ago
The Generalist's Patient and the Subspecialistover 24 years ago
Issues in Pooling Administrative Data for Economic EvaluationAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Treatment for Sanfilippo Syndrome Type A
2
Real-World Data: FACT vs Non-FACT CAR T Outcomes Compared
3
No Blood Biomarker Is Ready to Pick Psoriasis Therapy
4
World Alzheimer Day: Young-Onset Alzheimer Disease Often Misdiagnosed
5